Claritas Pharmaceuticals, Inc. engages in the development of next generation cannabinoid therapeutics. It also offers development programs for bone fracture healing, osteogenesis imperfecta, osteoporosis, and osteoporosis in Prader-Willi syndrome. The company was founded by Seth Yakatan on October 15, 2004 and is headquartered in San Rafael, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Claritas Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Claritas Pharmaceuticals Inc market cap is $1.13M.
What is the 52-week high for Claritas Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Claritas Pharmaceuticals Inc 52 week high is $0.0002 as of October 10, 2025.
What is the 52-week low for Claritas Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Claritas Pharmaceuticals Inc 52 week low is $0.00 as of October 10, 2025.
What is the 50-day moving average of Claritas Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Claritas Pharmaceuticals Inc 50-day moving average is $0.00.